Meredith A. Redd

This study compares CK-138 and dobutamine, showing CK-138 improves cardiac contractility without worsening myocardial energetics, unlike dobutamine which depletes ATP and shifts metabolism toward glycolysis.

This study shows glycaemic variability, not just hyperglycaemia, increases heart muscle dysfunction and myocardial injury risk in diabetes using genetic and experimental models.

This paper describes ulacamten, a novel cardiac myosin inhibitor with distinct binding and inhibitory properties compared to existing CMIs, showing efficacy in improving cardiac function in a rodent model of HFpEF.

This study identifies trace-level cytokines in PASC patients linked to cardiovascular symptoms and shows their impact on cardiomyocyte function using nanotechnology detection.

The paper creates an iPSC differentiation atlas and identifies TMEM88 as a regulator of mesendodermal development and blood pressure.

This study identifies HOPX as a molecular switch regulating cardiomyocyte progenitor and maturation gene programs, linking it to cardiac function and genetic variation.